Anders Ettrup Selected Research

eptinezumab

12/2023	Efficacy and safety of eptinezumab in patients with chronic migraine and medication-overuse headache: a randomized, double-blind, placebo-controlled study.
11/2023	Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial.
11/2023	Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trial.
11/2023	Pharmacokinetics and Safety of Eptinezumab in Healthy Chinese Participants: A Randomized Clinical Trial.
9/2023	Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial.
1/2023	Efficacy and safety of eptinezumab for migraine prevention in patients with prior preventive treatment failures: subgroup analysis of the randomized, placebo-controlled DELIVER study.
1/2023	Eptinezumab improved patient-reported outcomes and quality of life in patients with migraine and prior preventive treatment failures.
12/2022	Effects of eptinezumab on self-reported work productivity in adults with migraine and prior preventive treatment failure in the randomized, double-blind, placebo-controlled DELIVER study.
10/2022	Shift in diagnostic classification of migraine after initiation of preventive treatment with eptinezumab: post hoc analysis of the PROMISE studies.
7/2022	Optimization of acute medication use following eptinezumab initiation during a migraine attack: post hoc analysis of the RELIEF study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anders Ettrup Research Topics

Disease

20	Migraine Disorders (Migraine) 12/2023 - 01/2021
11	Headache (Headaches) 01/2023 - 01/2021
9	Major Depressive Disorder (Major Depressive Disorders) 12/2022 - 01/2019
5	Schizophrenia (Dementia Praecox) 01/2024 - 09/2011
4	Pain (Aches) 07/2022 - 01/2021
4	Nausea 06/2022 - 01/2019
3	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 09/2011
3	Neurobehavioral Manifestations 01/2021 - 01/2019
1	Cognitive Dysfunction 01/2024
1	Mental Disorders (Mental Disorder) 01/2024
1	Secondary Headache Disorders 12/2023
1	Photophobia (Light Sensitivity) 06/2022
1	Hyperacusis (Phonophobia) 06/2022
1	COVID-19 01/2022
1	Anaphylaxis (Anaphylactic Shock) 01/2022
1	Migraine with Aura (Familial Hemiplegic Migraine) 01/2022
1	Dizziness (Lightheadedness) 01/2022
1	Epilepsy (Aura) 01/2022
1	Vomiting 01/2022
1	Anxiety Disorders (Anxiety Disorder) 01/2021
1	Fatigue 01/2021
1	Anhedonia 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2019
1	Brain Diseases (Brain Disorder) 01/2016
1	Psychotic Disorders (Schizoaffective Disorder) 01/2013
1	Inflammation (Inflammations) 01/2013
1	Weight Loss (Weight Reduction) 10/2012
1	Hyperphagia (Overeating) 10/2012
1	Body Weight (Weight, Body) 10/2012
1	Overweight 10/2012
1	Obesity 10/2012
1	Amyloid Plaque 01/2010

Drug/Important Bio-Agent (IBA)

20	eptinezumabIBA 12/2023 - 01/2021
9	VortioxetineIBA 12/2022 - 01/2019
6	Calcitonin Gene-Related PeptideIBA 11/2023 - 01/2021
3	Monoclonal AntibodiesIBA 07/2022 - 01/2022
3	Antidepressive Agents (Antidepressants)IBA 01/2021 - 01/2019
2	Serotonin (5 Hydroxytryptamine)IBA 11/2020 - 10/2012
2	propylene diquat (PDQ(+))IBA 12/2019 - 01/2019
2	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 01/2016 - 01/2010
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 09/2015 - 09/2011
1	alpha7 Nicotinic Acetylcholine ReceptorIBA 01/2024
1	Pain-FreeIBA 07/2022
1	Fluoxetine (Prozac)FDA LinkGeneric 01/2022
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 11/2020
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2020
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 01/2020
1	Controlled SubstancesIBA 01/2019
1	Aripiprazole (Abilify)FDA Link 01/2017
1	Paliperidone Palmitate FDA Link 01/2017
1	Serotonin ReceptorsIBA 01/2016
1	Ligand-Gated Ion ChannelsIBA 09/2015
1	HaptoglobinsIBA 01/2013
1	C-Reactive ProteinIBA 01/2013
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2013
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2013
1	Neurotransmitter Agents (Neurotransmitter)IBA 10/2012
1	Proteins (Proteins, Gene)FDA Link 01/2010

Therapy/Procedure

3	Therapeutics 01/2023 - 01/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 10/2012